Re: Lilly to Discontinue Development of Evacetrapib
|
3
|
Resverlogix Corp.
|
Nov 05, 2015 11:10AM
|
Re: Someone Asked Me....
|
3
|
Resverlogix Corp.
|
Nov 20, 2015 11:01AM
|
Q1 Webcast
|
3
|
Resverlogix Corp.
|
Jan 29, 2016 12:22PM
|
Re: Not on the board, nor bored, but on board
|
3
|
Resverlogix Corp.
|
May 24, 2019 08:34AM
|
Re: 2019 Potential Events
|
3
|
Resverlogix Corp.
|
Jun 10, 2019 04:59PM
|
RVX in the next 5 weeks: ESC presentation 8/30
|
3
|
Resverlogix Corp.
|
Aug 26, 2015 07:26AM
|
Re: I still haven't gotten anything in the mail....
|
3
|
Resverlogix Corp.
|
Nov 20, 2017 10:31PM
|
Zenith abstract to be presented at AACR meeting 11/30
|
3
|
Zenith Epigenetics
|
Nov 18, 2016 12:44PM
|
Re: If you're not watching Resverlogix (RVX.CA or RVXCF) Now is the time to start....Explosive Potential
|
3
|
Resverlogix Corp.
|
Dec 26, 2019 10:48AM
|
Re: Confused
|
3
|
Zenith Epigenetics
|
Dec 19, 2015 11:26AM
|
Re: What is Mr. Market saying about RVX?
|
3
|
Resverlogix Corp.
|
Nov 26, 2018 03:56PM
|
Re: Bromodomain and extraterminal domain (BET) inhibitors in clinical development
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 09:42PM
|
Bioasis August Corporate Update Presentation
|
3
|
BIOASIS TECHNOLOGIES INC
|
Aug 18, 2019 10:17AM
|
New Blog: Current Treatments for Complement Mediated Diseases
|
3
|
Resverlogix Corp.
|
Dec 22, 2015 02:57PM
|
Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript
|
3
|
Zenith Epigenetics
|
Jan 06, 2021 10:50AM
|
The thread has been killed
|
3
|
Resverlogix Corp.
|
Jun 12, 2019 03:25PM
|
Re: RVXCF New 52 week high, $3.59 USD....
|
3
|
Resverlogix Corp.
|
Apr 23, 2019 10:41AM
|
Re: If you're not watching Resverlogix (RVX.CA or RVXCF) Now is the time to start....Explosive Potential
|
3
|
Resverlogix Corp.
|
Dec 26, 2019 11:07AM
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
3
|
Resverlogix Corp.
|
Jun 07, 2020 12:37PM
|
Re: We might already be at 125 events....
|
3
|
Resverlogix Corp.
|
Oct 26, 2017 01:58PM
|